MONTREAL (AP) — MONTREAL (AP) — Milestone Pharmaceuticals Inc. (MIST) on Monday reported a loss of $15.1 million in its third quarter.
On a per-share basis, the Montreal-based company said it had a loss of 35 cents.
The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 38 cents per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MIST at https://www.zacks.com/ap/MIST
Advertisement